NCT02205138 - Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

January 25, 2021

Conditions

Degenerative Disc Disease

Interventions

DRUG

ALLOB® cells with ceramic scaffold

Each patient will undergo a single administration of ALLOB®/ceramic scaffold mix into the lumbar interbody fusion site under anaesthesia

Trial Locations (8)

Investigating site BE01, Brussels

Investigating site BE03, Brussels

Investigating site BE05, Brussels

Investigating site BE02, Charleroi

Investigating site BE04, Genk

Investigating site BE08, Kortrijk

Investigating site BE07, Liège

Investigating site BE06, Mons